CCONH
RMD icon

Crosby Company of New Hampshire’s ResMed RMD Stock Holding History

Crosby Company of New Hampshire’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-111,883
Closed -$13.7M – 1
2019
Q2 		$13.7M Sell
111,883
-500
-0.4% -$55.4K 100% 1
2019
Q1 		$11.7M Buy
112,383
+18,365
+20% +$1.9M 100% 1
2018
Q4 		$10.7M Hold
94,018
– – 100% 1
2018
Q3 		$10.8M Hold
94,018
– – 100% 1
2018
Q2 		$9.74M Hold
94,018
– – 100% 1
2018
Q1 		$9.26M Hold
94,018
– – 100% 1
2017
Q4 		$7.96M Buy
+94,018
New +$7.77M 100% 1

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Crosby Company of New Hampshire's RMD Position: Q3 2019 in Review

Crosby Company of New Hampshire sold out of ResMed (RMD) in Q3 2019, closing a stake of 111,883 shares — an estimated $13.7M sold.

Crosby Company of New Hampshire first reported a position in RMD in Q4 2017 and held it in 7 quarters. The position peaked at $13.7M in Q2 2019. 528 funds tracked by Wall St. Rank hold RMD as of Q3 2019.

  • Crosby Company of New Hampshire reported no remaining ResMed position as of Q3 2019 after selling out during the quarter.
  • Crosby Company of New Hampshire sold 111,883 ResMed shares in Q3 2019, an estimated $13.7M.
  • Crosby Company of New Hampshire first reported a position in ResMed in Q4 2017 and held it in 7 quarters.
  • Crosby Company of New Hampshire's ResMed position peaked at $13.7M in Q2 2019.
  • 528 funds tracked by Wall St. Rank held ResMed as of Q3 2019.

Based on Crosby Company of New Hampshire's 13F filing for Q3 2019.